BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33004778)

  • 41. Drug hypersensitivity in children: a retrospective analysis of 101 pharmacovigilance reports.
    Katsogiannou M; Carsin A; Mazenq J; Dubus JC; Gervoise-Boyer MJ
    Eur J Pediatr; 2021 Feb; 180(2):495-503. PubMed ID: 33155108
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Delayed positive drug provocation tests to beta-lactams with flare-up reactions of skin tests sites.
    Pérez-Codesido S; Bourrain JL; Demoly P; Chiriac AM
    Clin Exp Allergy; 2021 Mar; 51(3):499-502. PubMed ID: 33300220
    [No Abstract]   [Full Text] [Related]  

  • 43. Diagnosing β-Lactam Hypersensitivity.
    Gaeta F; Torres MJ; Valluzzi RL; Caruso C; Mayorga C; Romano A
    Curr Pharm Des; 2016; 22(45):6803-6813. PubMed ID: 27712573
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Natural History of Benign Nonimmediate Allergy to Beta-Lactams in Children: A Prospective Study in Retreated Patients After a Positive and a Negative Provocation Test.
    Tonson la Tour A; Michelet M; Eigenmann PA; Caubet JC
    J Allergy Clin Immunol Pract; 2018; 6(4):1321-1326. PubMed ID: 29175371
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children.
    Kidon MI; Kang LW; Chin CW; Hoon LS; See Y; Goh A; Lin JT; Chay OM
    Pediatrics; 2005 Nov; 116(5):e675-80. PubMed ID: 16230465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs].
    Chalabianloo F
    Tidsskr Nor Laegeforen; 2012 Sep; 132(17):1961-3. PubMed ID: 23007360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-immediate hypersensitivity reactions to beta-lactam antibiotics in children - our 10-year experience in allergy work-up.
    Atanaskovic-Markovic M; Gaeta F; Medjo B; Gavrovic-Jankulovic M; Cirkovic Velickovic T; Tmusic V; Romano A
    Pediatr Allergy Immunol; 2016 Aug; 27(5):533-8. PubMed ID: 26999792
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug Allergy Profile From a National Drug Allergy Registry.
    Al-Ahmad M; Edin J; Musa F; Rodriguez-Bouza T
    Front Pharmacol; 2020; 11():555666. PubMed ID: 33542684
    [No Abstract]   [Full Text] [Related]  

  • 49. Pediatric Drug Allergy.
    Prosty C; Copaescu AM; Gabrielli S; Mule P; Ben-Shoshan M
    Immunol Allergy Clin North Am; 2022 May; 42(2):433-452. PubMed ID: 35469628
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Specific Aspects of Drug Hypersensitivity in Children.
    Bergmann M; Caubet JC
    Curr Pharm Des; 2016; 22(45):6832-6851. PubMed ID: 27669963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral challenge without skin tests in children with non-severe beta-lactam hypersensitivity: Time to change the paradigm?
    Moral L; Caubet JC
    Pediatr Allergy Immunol; 2017 Dec; 28(8):724-727. PubMed ID: 28892222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Optimal step doses for drug provocation tests to prove beta-lactam hypersensitivity.
    Chiriac AM; Rerkpattanapipat T; Bousquet PJ; Molinari N; Demoly P
    Allergy; 2017 Apr; 72(4):552-561. PubMed ID: 27569064
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Basophil activation tests in the evaluation of immediate drug hypersensitivity.
    Sanz ML; Gamboa PM; Mayorga C
    Curr Opin Allergy Clin Immunol; 2009 Aug; 9(4):298-304. PubMed ID: 19483617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short and extended provocation tests have similar negative predictive value in non-immediate hypersensitivity to beta-lactams in children.
    Regateiro FS; Rezende I; Pinto N; Abreu C; Carreiro-Martins P; Gomes ER
    Allergol Immunopathol (Madr); 2019; 47(5):477-483. PubMed ID: 30910271
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs.
    Kowalski ML; Asero R; Bavbek S; Blanca M; Blanca-Lopez N; Bochenek G; Brockow K; Campo P; Celik G; Cernadas J; Cortellini G; Gomes E; Niżankowska-Mogilnicka E; Romano A; Szczeklik A; Testi S; Torres MJ; Wöhrl S; Makowska J
    Allergy; 2013 Oct; 68(10):1219-32. PubMed ID: 24117484
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PPL and MDM skin test: new test kit is helpful in detecting immediate-type allergy to beta-lactams.
    Treudler R; Simon JC
    J Dtsch Dermatol Ges; 2007 Apr; 5(4):286-92. PubMed ID: 17376092
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Allergy to betalactam antibiotics in children].
    Caubet JC; Eigenmann AP
    Rev Med Suisse; 2008 Apr; 4(154):1014-7. PubMed ID: 18557529
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypersensitivity Reactions to Antiepileptic Drugs in Children: Epidemiologic, Pathogenetic, Clinical, and Diagnostic Aspects.
    Kuyucu S; Caubet JC
    J Allergy Clin Immunol Pract; 2018; 6(6):1879-1891.e1. PubMed ID: 30104171
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and cost effectiveness of supervised ambulatory drug provocation tests in children with mild non-immediate reactions to beta-lactams.
    Jaoui A; Delalande D; Siouti S; Benoist G; Sève E; Ponvert C; Scheinmann P; Faour H; Neuraz A; Garcelon N; Delacourt C; Lezmi G
    Allergy; 2019 Dec; 74(12):2482-2484. PubMed ID: 31087349
    [No Abstract]   [Full Text] [Related]  

  • 60. Skin tests are important in children with β-lactam hypersensitivity, but may be reduced in number.
    Diaferio L; Chiriac AM; Leoni MC; Castagnoli R; Caimmi S; Miniello VL; Demoly P; Caimmi D
    Pediatr Allergy Immunol; 2019 Jun; 30(4):462-468. PubMed ID: 30734416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.